knowledge -WSS

knowledge

author：comprehensive 2025-10-01 02:14:41 - browse：6278

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： What Henrietta Lacks settlement says about racism in medicine

WSS

Microsoft strikes partnership with Duke Health to advance health AI

What Henrietta Lacks settlement says about racism in medicine

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Verily hires former Apple Health leader as chief scientific officer

Readout Newsletter: What happened with Sarepta's Duchenne data

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

hotspot

knowledge

hotspot

Peter Hotez and the public health issue of online harassment

Humana, CVS hope to turn members into patients at clinics

Supreme Court strikes down use of affirmative action

Gilgo Beach: Police identify another victim in serial killing investigation

The high cost of giving birth even with insurance

Biden's order seeks to regulate AI risk without stifling innovation

In age of alternative facts, a scholarly course on calling out crap

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ChatGPT in medicine: STAT answers readers' burning questions

WHO may add ‘noma' to its list of neglected tropical diseases

hotspot

White House drug shortage group privately met with industry

Telehealth options flood the market as retailers push virtual care

Microsoft strikes partnership with Duke Health to advance health AI

Cassava reveals details — and problems — with Alzheimer's study

FDA has safety concerns on CRISPR

'Ancient DNA,' 23andMe reveal African American ancestries

knowledge

focus

focus

leisure time